Literature DB >> 22353357

Considering hidradenitis suppurativa as a bacterial biofilm disease.

Sandeep Kathju1, Leslie-Ann Lasko, Paul Stoodley.   

Abstract

Hidradenitis suppurativa (HS) is a chronic inflammatory disease of the skin that results in a relapsing course of painful draining sinuses and abscesses. The disease manifests largely in the apocrine gland-bearing regions of the body (axillary, inguinal and anogenital areas) and is usually treated by antibiotics and/or surgery. The exact pathogenesis of HS is still in dispute, but likely multifactorial; in some instances, a genetic component has been demonstrated. While much attention has been given to the cellular and molecular biology of the host tissues affected by HS, rather less has been given to the bacteria involved (most commonly Staphylococci or Streptococci). We note that the characteristics of HS comport exactly with the features of bacterial biofilm-based infections, and examined a case where HS of the buttocks had progressed to an advanced stage. Physical examination of the sinus tracks at surgery revealed a mucinous accumulation consistent with biofilm formation. Confocal microscopic examination using Live/Dead staining revealed clusters of bacteria attached to the sinus luminal surfaces. The paradigmatic clinical features of HS, coupled with the adherent bacterial communities we observe here, suggest that HS should be considered in the expanding spectrum of bacterial biofilm-based disorders.
© 2012 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22353357     DOI: 10.1111/j.1574-695X.2012.00946.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  15 in total

Review 1.  [Hidradenitis suppurativa/acne inversa: An update].

Authors:  J Kirschke; S Hessam; F G Bechara
Journal:  Hautarzt       Date:  2015-06       Impact factor: 0.751

Review 2.  The critical role of macrophages in the pathogenesis of hidradenitis suppurativa.

Authors:  Ahmed Shah; Raed Alhusayen; Saeid Amini-Nik
Journal:  Inflamm Res       Date:  2017-06-27       Impact factor: 4.575

Review 3.  Medical and Surgical Treatment of Hidradenitis Suppurativa: A Review.

Authors:  Nicolò Scuderi; Ambra Monfrecola; Luca Andrea Dessy; Gabriella Fabbrocini; Matteo Megna; Giuseppe Monfrecola
Journal:  Skin Appendage Disord       Date:  2017-03-21

Review 4.  Hidradenitis suppurativa.

Authors:  Robert Sabat; Gregor B E Jemec; Łukasz Matusiak; Alexa B Kimball; Errol Prens; Kerstin Wolk
Journal:  Nat Rev Dis Primers       Date:  2020-03-12       Impact factor: 52.329

5.  Acne inversa (Hidradenitis suppurativa): A review with a focus on pathogenesis and treatment.

Authors:  Uwe Wollina; André Koch; Birgit Heinig; Thomas Kittner; Andreas Nowak
Journal:  Indian Dermatol Online J       Date:  2013-01

Review 6.  Update on hidradenitis suppurativa: connecting the tracts.

Authors:  Liza Gill; Melissa Williams; Iltefat Hamzavi
Journal:  F1000Prime Rep       Date:  2014-12-01

Review 7.  Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa.

Authors:  Christina Fotiadou; Efstratios Vakirlis; Dimitrios Ioannides
Journal:  Clin Cosmet Investig Dermatol       Date:  2016-10-19

8.  Successful combined antibiotic therapy with oral clindamycin and oral rifampicin for pyoderma gangrenosum in patient with PASH syndrome.

Authors:  Marie Lamiaux; Fadia Dabouz; Maud Wantz; Damien Lebas; Audrey Lasek; Domitille Courivaud; Philippe Modiano
Journal:  JAAD Case Rep       Date:  2017-12-18

Review 9.  Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment.

Authors:  Maddalena Napolitano; Matteo Megna; Elena A Timoshchuk; Cataldo Patruno; Nicola Balato; Gabriella Fabbrocini; Giuseppe Monfrecola
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-04-19

10.  Ertapenem rescue therapy in hidradenitis suppurativa.

Authors:  Adam A Chahine; Amanda F Nahhas; Taylor L Braunberger; Pranita V Rambhatla; Iltefat H Hamzavi
Journal:  JAAD Case Rep       Date:  2018-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.